key: cord-0772677-aumpa1zf authors: Karamese, Murat; Ozgur, Didem; Tarhan, Ceyda; Altintas, Susamber D; Caliskan, Okan; Tuna, Aysegul; Kazci, Saliha; Karadavut, Mursel; Gumus, Abdullah; Apaydin, Gozde; Mumcu, Necati; Coruh, Onur; Tutuncu, Emin E title: Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR date: 2021-07-05 journal: Future microbiology DOI: 10.2217/fmb-2020-0134 sha: 09cb782d196bfbffad3ba189d7d0f7ab50906d83 doc_id: 772677 cord_uid: aumpa1zf AIM: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. MATERIALS & METHODS: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. RESULTS: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive samples out of 7853 were 487; however, the number of nonrepeating positive patient was 373 (4.8%). Cough and fever were the most common symptoms in positive cases. CONCLUSION: Epidemiologic studies should be performed about the prevalence of SARS-CoV-2 infection to better understand the effect of the virus across the world. The study was approved by both the Republic of Turkey Ministry of Health COVID-19 Scientific Research Evaluation Commission (approval date: 2 May 2020; number: 2020-05-03T18 02 30) and the Local Ethics Committee of Kafkas University Faculty of Medicine (approval date: 6 May 2020 number: 80576354-050-99/129). A total of 10,000 samples from 2 April to 30 May were tested for SARS-CoV-2 infection in Kars, Igdır and Ardahan, cities that are located in the East of Turkey; however, 7853 cases were evaluated who had typical respiratory infection symptoms such as fever, cough and shortness of breath or close contact with a COVID-19 patient. The patients who had any symptoms of COVID-19 disease had a RT-PCR SARS-CoV-2 test. The samples were collected day by day between 1 April and 29 May and unsuitable, flowed and leaked samples were rejected. In this study, the screening RT-PCR test results (n = 2147) were excluded ( Figure 1 ). All RT-PCR tests from three cities were performed at Kafkas University, Faculty of Medicine, Department of Medical Microbiology, Molecular Microbiology Laboratory, Kars, Turkey. The detection of SARS-CoV-2 virus in respiratory specimens especially in nasopharyngeal swabs was detected by RT-PCR technique via using Roche Lightcycler-96 device (Roche Diagnostic Systems, Basel, Switzerland). RT-PCR was performed using SARS-CoV-2 (2019-nCoV) qPCR Detection Kit (Bioeksen R&D,İstanbul, Turkey) that is targeting SARS-CoV-2-specific RNA-dependent RNA polymerase gene fragment. The final PCR concentration was 20 μl (10 μl qPCR master mix, 5 μl primer/probe set and 5 μl template). The nucleic acid amplification was performed with the following PCR steps: reverse transcription stage (45 • C, 15 min, one cycle), initial activation stage (95 • C, 3 min, one cycle) and amplification stage (denaturation: 95 • C, 5 s, annealing and extension: 55 • C, 35 s, 45 cycles). All samples were run together with a SARS-Cov-2-positive control and -negative control (H 2 O). For data analysis, 2-CT method was used and CT values were less than 40 was defined as a positive test. A total of 7853 cases were included from three neighboring cities. Of those, 4642 (59.1%) were male and 3211 (40.8%) were female. The mean age of all cases was 38.14 ± 21.10. The nasopharyngeal swab samples (n = 7826, 99.7%) were the most preferred respiratory specimens. Detailed descriptive characteristics of all patients are in Table 1 . The number of total positive samples was 487; however, the number of nonrepeating positive patient was 373 (4.8%). The distribution of nonrepeating positive patients was as follows: Kars (n = 181, 48.5%), Igdır (n = 147, 39.4%) and Ardahan (n = 45, 12.1%). Of those, 156 (41.8%) were male and 217 (58.2%) were female. The mean age of positive cases was 36.96 ± 20.25. Cough and fever were the most common symptoms in positive cases (n = 111, 29.8% and n = 98, 26.3%, respectively); however, most of the positive cases were asymptomatic (n = 198). Additionally, respiratory diseases such as asthma and chronic obstructive pulmonary disease were the most recorded additional diseases for positive cases. Detailed information about the positive cases are in Table 2 . The statistical analysis showed that there was a significant difference between positive and negative cases regarding gender (X 2 = 50.903; p = 0.000), while no statistically significant difference was detected between them where age was concerned (Z = -0.980; p = 0.327). To our knowledge, this is one of the first epidemiologic studies about the RT-PCR positivity of suspected SARS-CoV-2 cases in our country. In 60 days, we studied 10,000 specimens to detect SARS-CoV-2; however, the screening tests were excluded (n = 2147). The positivity rates may vary depending on the study population and location. A study reported that 38% of 4880 cases were detected positive by RT-PCR [4] . Similarly, another study reported that future science group www.futuremedicine.com the positivity rate was 51% [7] . The positivity rate of our population was 4.75%, which is almost compatible with the national positivity rates announced every day by the Minister of Health [8] . Pan et al. performed an epidemiologic study with 32,583 laboratory confirmed COVID-19 cases and reported that 51.6% of cases were female [9] . The percentages of positive male and female are parallel with the current literature. Among the 3211 female and 4642 male cases, females had a higher rate (n = 217, 6.75%) of confirmed cases compared with males (n = 156, 3.36%). This is parallel with the current literature. Although, the number of tested males was more than one and a half times the number of tested females, the positivity rate in females was nearly twofold that of males (6.75 vs 3.36%). In our study, most positive cases were in the 21-40 (40.8%) and 41-60 (28.9%) age ranges, respectively. Similarly, a study from China performed with 44,672 cases indicated that most positive cases were in the 30-79 (87%) age range [10] . The average range was generally above 55 years [7] ; however, in our study data the average age was roughly 38 years. This may be due to the inclusion of a large number of asymptomatic and close-contact patients who were younger. On the other hand, cough and fever were the most seen symptoms in positive cases, respectively; however, most of the cases were those who had close contact with a COVID-19 patient (asymptomatic patients). Most of the studies reported that the number of asymptomatic patients were high, and the most common symptoms were fever and cough [3, 11, 12] . Interestingly, total positive percentage was associated with gender but not age, in our study. By contrast, a study reported that SARS-CoV-2 infection was statistically related with both age and gender [4] . In conclusion, epidemiologic studies should be performed about the prevalence of SARS-CoV-2 infection to better understand the effect of the virus around the world. On the other hand, prevalence of PCR positives among close contact screening and age and sex distribution may reflect healthcare access or behavior and this should be analyzed in future studies. Our study has some limitations. First, this was a retrospective study. Second, more detailed information should have been obtained because there were relatively large amounts of missing data for some outcomes. Third, the pandemic is still ongoing and the data about SARS-CoV-2 positivity could change; however, we wanted to share the suspected patients' rates before the screening test had been started in our country. Fourth, information such as outpatient/inpatient was not available. Finally, the asymptomatic patients were not followed up in our study. The main aim was to present the prevalence of RT-PCR positivity of suspected COVID-19 patients. Further studies about the CT value difference of symptomatic and asymptomatic patients with a large population should be performed. • We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighboring cities located in the east of Turkey. • Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. • Cough and fever were the most common symptoms in positive cases. • Epidemiologic studies should be performed about the prevalence of SARS-CoV-2 infection to better understand the effect of the virus all over the world. • The prevalence of PCR positives among close contact screening and age and sex distribution may reflect healthcare access or behavior and this should be analyzed in future studies. The epidemiology, diagnosis and treatment of COVID-19 Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Sensitivity of chest CT for COVID-19: comparison to RT-PCR Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Republic of Turkey Ministry of Health Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis The authors would like to thank the physicians and/or workers of Kars, Igdır and Ardahan Pandemic Hospitals for their invaluable support to the preparation and transportation of samples. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript. The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.